Precigen (PGEN) Exchange Rate Effect (2013 - 2026)
Precigen (PGEN) reported Exchange Rate Effect of -$3000.0 for Q1 2026, down 250.0% year-over-year from $2000.0 in Q1 2025, and down 115.0% quarter-over-quarter from $20000.0 in Q4 2025.
Precigen (PGEN) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Precigen (PGEN) has 14 years of Exchange Rate Effect data on file, last reported at -$3000.0 in Q1 2026.
- Exchange Rate Effect for Q1 2026 came in at -$3000.0, down 250.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $30000.0 (down 14.29% YoY), and the FY2025 annual result was $35000.0, up 229.63% from the prior year.
- Exchange Rate Effect declined to -$3000.0 in Q1 2026 per PGEN's latest filing, from $20000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $70000.0 in Q3 2024 and troughed at -$333000.0 in Q3 2022.
- A 5-year average of -$67176.5 and a median of -$23000.0 in 2022 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect tumbled 1990.91% in 2022, then surged 1100.0% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at -$23000.0 in 2022, then soared by 39.13% to -$14000.0 in 2023, then soared by 85.71% to -$2000.0 in 2024, then surged by 1100.0% to $20000.0 in 2025, then slumped by 115.0% to -$3000.0 in 2026.
- Business Quant data shows PGEN's Exchange Rate Effect at -$3000.0 in Q1 2026, $20000.0 in Q4 2025, and $10000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 8.68 Mn |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | -3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Sep 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Dec 31, 2024 | -2,000.00 |
| Sep 30, 2024 | 70,000.00 |
| Sep 30, 2024 | 70,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Jun 30, 2024 | -35,000.00 |
| Mar 31, 2024 | -60,000.00 |
| Mar 31, 2024 | -60,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Dec 31, 2023 | -14,000.00 |